Skip to content

Category Archives: Stent-graft

Endovascular abdominal aortic aneurysm repair > Under severe regulatory body scrutiny > Cost effectiveness as a function of cost and clinical benefit > National Institute of Clinical Excellence NICE > Unfit for open repair and not high risk > Endovascular Aneurysm Repair EVAR Trials > Dutch Randomized Endovascular Aneurysm Management DREAM > Open Versus Endovascular Repair OVER trial > Multi-center experience > Cook > Medtronic > Gore

Are there two populations of patients considered for EVAR, those fit for open repair and those unfit? Is there ever more evidence that the fitness of the patient is of crucial importance in the decision-making? Are trial results pointing toward EVAR being of poor or even no benefit in the very sick patients?

IIP > read […]

V.C.s lead Spin-Off of Boston Scientific Unit > TriVascular2 > Divest nonstrategic assets > $65 million from previous and new investors > Series A preferred round to finance spinout > Programs Boston Scientific suspended in June 2006 > MPM Capital > New Enterprise Associates > Delphi Ventures > Kearny Venture Partners > Complete clinical development > Endovascular aneurysm repair EVAR > Stent-graft

Does TriVascular address an opportunity that justifies the new investments by MPM Capital and NEA? Is it feasible to address a broader patient population requiring endovascular repair of aortic aneurysms with the novel stent-graft from TriVascular? Will these patients have a safe and permanent alternative to open surgical repair?

IIP > Read on here…
TriVascular2, a company […]